Objective
Human embryonic stem cell (hESC) research holds promise for regenerative therapies, offers a tool for drug discovery and toxicity tests, for studying human development, disease physiology and gene control. hESC lines are derived in an increasing number of laboratories accompanied by a widening scope of usage and application. This trend has not diminished since human induced pluripotent stem cells (hiPSC) became available as research and use of hESC and hiPSC rapidly co-develop. The advancing scope of the field, the increasing count of researchers, laboratories and institutions working with pluripotent stem cells (hPSC) and the ever growing number of hESC and hiPSC lines poses novel challenges, while further justifying the recognized need for a registry of hESC. This need has been addressed by establishing the European hESC registry (EU-hESCreg). The proposed project aims at sustaining and improving operability of EU-hESCreg, and to expand its content and usability in order to respond to the existing and anticipated challenges in the field. The European human pluripotent stem cell registry (EU-hPSCreg) will adapt its registration content and requirements to accommodate hESC and hiPSC. The inclusion of these most relevant pluripotent stem cells (hPSC) will broaden comparability and standardization of cell lines, advance knowledge dissemination and hence reduce the need for generating new hESC lines. The objective of the EU-hPSCreg is to promote access to hPSC lines and to provide transparency about their characteristics, to contribute to the harmonization of hPSC usage and develop it into an international hub. The project will (i) implement transparent criteria for registration, qualification and validation of hPSC, (ii) establish efficient means and tools for internal and external communication and dissemination of information , (iii) provide a reliable technical and regulatory basis for operation and (iv) establish efficient and strategic management.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences medical biotechnology cells technologies stem cells
- medical and health sciences basic medicine physiology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-Adhoc-2007-13
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
10117 Berlin
Germany
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.